William D. Haydon - Mar 4, 2022 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
SVP, GM Pain Franchise
Signature
/s/ Mojirade James, as attorney-in-fact for William D. Haydon
Stock symbol
AVNS
Transactions as of
Mar 4, 2022
Transactions value $
$0
Form type
4
Date filed
3/8/2022, 10:31 AM
Next filing
Mar 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Award $0 +12.9K +79.58% $0.00 29.2K Mar 4, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents time-based restricted share units awarded pursuant to the Issuer's 2021 Long Term Incentive Plan. The award will vest 1/3 on March 4, 2023, 1/3 on March 4, 2024 and 1/3 on March 4, 2025.
F2 Total beneficially owned includes 436 shares acquired on June 30, 2021 and 147 shares aquired on December 31, 2021 under the Issuer's Employee Stock Purchase Plan.